脑室-心房分流术治疗特发性颅内压增高
本研究回顾单中心10年电子病历,纳入6例特发性颅内压增高(IIH)患者共8次脑室-心房(VA)分流术,均为二次手术,平均随访58±25个月;50个月时75%的VA分流存活,而IIH患者中脑室-胸膜分流存活率仅58.3%,作者认为VA分流是安全有效的脑脊液分流替代选择。
要点
- VA分流在IIH中均为二次手术,50个月存活率75%,高于脑室-胸膜分流的58.3%。
- 仅1例因VA分流特异性并发症(远端血栓)需翻修,另1例因急性颅内出血翻修。
- 所有患者治疗获优化,但仅2例有记录的视乳头水肿消退。
核心结论
- 作者认为脑室-心房分流是特发性颅内压增高脑脊液分流的安全有效的替代选择。
- 本系列中仅1例分流因VA分流特异性并发症而翻修。
研究设计与样本
- 回顾性病例系列,回顾10年期间电子病历。
- 排除标准为同一分流置入重复、未置入VA分流、儿科患者及非IIH指征。
- 共识别6例患者的8次VA分流术,置入时平均年龄34±10岁,平均随访58±25个月。
主要发现
- 所有分流均为二次手术:2例来自腰-胸膜分流,2例来自脑室-胸膜分流,2例来自脑室-心房分流,各1例来自脑室-腹膜分流和腰-腹膜/脑室-腹膜联合分流。
- 50个月时75%的VA分流存活,而IIH患者中脑室-胸膜分流仅58.3%存活。
- 1例因急性颅内出血在第1天翻修,1例因远端部位血栓在第57天翻修,两例分流后来均重新置入。
- 从最新门诊信件看,所有患者治疗均获优化,但仅2例有记录的视乳头水肿在术后消退。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: CSF diversion is a recognised intervention in idiopathic intracranial hypertension (IIH), particularly in the presence of vision-threatening papilledema. Although ventriculo-atrial (VA) shunt insertion is a routine neurosurgical procedure, ventriculoperitoneal and lumboperitoneal shunts have been mostly used in this particular indication. This study aims to look at a single centre's experience with VA shunts in idiopathic intracranial hypertension (IIH). METHODS: Retrospective case series with a review of electronic records over a 10-year period; exclusion criteria were duplication of same shunt insertion, no VA shunt insertion, paediatric patients and indication other than IIH. Notes were reviewed for demographics, shunt survival (defined by time prior to revision) and reasons for revision. RESULTS: Eight VA shunt procedures were identified in 6 patients (mean age at insertion 34 ± 10 years) with a mean follow-up of 58 ± 25 months. All shunts were secondary procedures; 2 revisions from lumbo-pleural, 2 from ventriculopleural, 2 from ventriculoatrial and one each from ventriculoperitoneal and combined lumbo-/ventriculoperitoneal. At 50 months, 75% of VA shunts had survived, compared to only 58.3% of VPleural shunts in patients with IIH. Revisions were required due to acute intracranial bleed (1 case)-revised at day 1, and thrombus at distal site (1 case)-revised at day 57. Both shunts were later reinserted. From the latest clinic letters, all patients had their treatment optimised with this procedure, although only two patients had documented resolved papilloedema post-procedure. CONCLUSIONS: Ventriculo-atrial shunts are a safe and efficacious alternative option for CSF diversion in IIH. In this series, only 1 shunt was revised for a VA shunt-specific complication.
引用
- Momin SMB, Mullins SR, Craven CL, et al. Ventriculo-atrial shunt in idiopathic intracranial hypertension. Acta Neurochir (Wien). 2024. PMID: 38386079. doi:10.1007/s00701-024-05985-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。